Casdin Capital, LLC Q3 2020 Filing
Filed November 16, 2020
Portfolio Value
$2.2T
Holdings
45
Report Date
Q3 2020
Filing Type
13F-HR
All Holdings (45 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | NVTA1EURINVITAE CORP | 9,033,943 | $391.6B | 17.54% | |
| 2 | BLFSBIOLIFE SOLUTIONS INC | 5,840,107 | $169.0B | 7.57% | |
| 3 | RLAYRELAY THERAPEUTICS INC | 3,808,894 | $162.2B | 7.26% | |
| 4 | 2L9BLUEPRINT MEDICINES CORP | 1,550,000 | $143.7B | 6.43% | |
| 5 | FATEFATE THERAPEUTICS INC | 3,050,000 | $121.9B | 5.46% | |
| 6 | —MYOKARDIA INC | 870,000 | $118.6B | 5.31% | |
| 7 | ALNYALNYLAM PHARMACEUTICALS INC | 620,000 | $90.3B | 4.04% | |
| 8 | TWSTTWIST BIOSCIENCE CORP | 1,000,000 | $76.0B | 3.40% | |
| 9 | SRPTSAREPTA THERAPEUTICS INC | 530,000 | $74.4B | 3.33% | |
| 10 | AGIOAGIOS PHARMACEUTICALS INC | 1,750,000 | $61.3B | 2.74% | |
| 11 | RVMDREVOLUTION MEDICINES INC | 1,634,535 | $56.9B | 2.55% | |
| 12 | GBIOGBXGENERATION BIO CO | 1,611,214 | $49.8B | 2.23% | |
| 13 | —BLUEBIRD BIO INC | 915,000 | $49.4B | 2.21% | |
| 14 | BNRBURNING ROCK BIOTECH LTD | 1,922,150 | $48.2B | 2.16% | |
| 15 | DNLIDENALI THERAPEUTICS INC | 1,310,000 | $46.9B | 2.10% | |
| 16 | CDXSCODEXIS INC | 3,985,000 | $46.8B | 2.09% | |
| 17 | CDNACAREDX INC | 1,193,335 | $45.3B | 2.03% | |
| 18 | PACBPACIFIC BIOSCIENCES CALIF IN | 4,500,000 | $44.4B | 1.99% | |
| 19 | ONCBEIGENE LTD | 150,000 | $43.0B | 1.92% | |
| 20 | ALLOALLOGENE THERAPEUTICS INC | 945,000 | $35.6B | 1.60% | |
| 21 | ADPTADAPTIVE BIOTECHNOLOGIES COR | 713,125 | $34.7B | 1.55% | |
| 22 | ADVMCHFADVERUM BIOTECHNOLOGIES INC | 2,750,000 | $28.3B | 1.27% | |
| 23 | —MAGENTA THERAPEUTICS INC | 3,346,034 | $22.8B | 1.02% | |
| 24 | CRSPCRISPR THERAPEUTICS AG | 266,430 | $22.3B | 1.00% | |
| 25 | GBTUSDGLOBAL BLOOD THERAPEUTICS IN | 395,000 | $21.8B | 0.98% | |
| 26 | AMRSEURAMYRIS INC | 7,390,000 | $21.6B | 0.97% | |
| 27 | —CONSTELLATION PHARMCETICLS I | 980,000 | $19.9B | 0.89% | |
| 28 | TSHATAYSHA GENE THERAPIES INC | 820,440 | $18.4B | 0.82% | |
| 29 | ALECALECTOR INC | 1,650,000 | $17.4B | 0.78% | |
| 30 | DMTKQDERMTECH INC | 1,428,572 | $17.1B | 0.76% | |
| 31 | ZLABZAI LAB LTD | 190,000 | $15.8B | 0.71% | |
| 32 | BLIUSDBERKELEY LTS INC | 200,000 | $15.3B | 0.68% | |
| 33 | BMY-RBRISTOL-MYERS SQUIBB CO | 6,250,000 | $14.1B | 0.63% | |
| 34 | FULCFULCRUM THERAPEUTICS INC | 1,441,176 | $11.4B | 0.51% | |
| 35 | GBYSANGAMO THERAPEUTICS INC | 1,080,000 | $10.2B | 0.46% | |
| 36 | IOVAIOVANCE BIOTHERAPEUTICS INC | 290,000 | $9.5B | 0.43% | |
| 37 | ILMNILLUMINA INC | 30,000 | $9.3B | 0.42% | |
| 38 | BDTXBLACK DIAMOND THERAPEUTICS I | 289,395 | $8.7B | 0.39% | |
| 39 | ORTXUSDORCHARD THERAPEUTICS PLC | 1,870,000 | $7.7B | 0.34% | |
| 40 | DYNDYNE THERAPEUTICS INC | 370,000 | $7.5B | 0.33% | |
| 41 | —TURNING POINT THERAPEUTICS I | 75,000 | $6.6B | 0.29% | |
| 42 | ORICORIC PHARMACEUTICALS INC | 251,515 | $6.3B | 0.28% | |
| 43 | LEGNLEGEND BIOTECH CORP | 139,661 | $4.3B | 0.19% | |
| 44 | STOKSTOKE THERAPEUTICS INC | 120,000 | $4.0B | 0.18% | |
| 45 | DCPHEURDECIPHERA PHARMACEUTICALS IN | 65,000 | $3.3B | 0.15% |